A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea - PubMed (original) (raw)
Clinical Trial
doi: 10.1038/sj.ijir.3900944.
T Y Ahn, J J Kim, S C Kim, J S Paick, J K Suh, H S Kim, Y K Kim, W H Lee, B H Oh, C H Park, W S Ryu, T G Chung, S W Kim, W H Lee, D G Moon, D S Ryu, K K Seo, D K Kim, D S Lee
Affiliations
- PMID: 12789384
- DOI: 10.1038/sj.ijir.3900944
Clinical Trial
A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea
H K Choi et al. Int J Impot Res. 2003 Apr.
Abstract
The efficacy and safety of sildenafil was evaluated in a randomiSed, double-blind, placebo-controlled, flexible-dose study in Korean men aged 28-78 y with erectile dysfunction (ED) of broad-spectrum aetiology and more than 6 months duration. A total of 133 patients were randomised at six centres in Korea to receive either sildenafil (50 mg initially, increased if necessary to l00 mg or decreased to 25 mg depending on efficacy and tolerance) (n=66) or matching placebo (n=67) taken on an 'as needed' basis l h prior to anticipated sexual activity for a period of 8 weeks. At the end of this time, the primary efficacy variables relating to the achievement and maintenance of erections sufficient for sexual intercourse, and the secondary efficacy variables, which included: (1) the five separate domains of sexual functioning of the International Index of Erectile Function (IIEF) scale, (2) the percentage of successful intercourse attempts, and (3) a global assessment of erections, were all statistically significantly improved by sildenafil in comparison with placebo (P&<0.0001). Treatment-related adverse events occurred in 56.1% of patients receiving sildenafil and 20.9% receiving placebo. The most common adverse events with sildenafil were vasodilatation (flushing), headache and abnormalities in colour vision (31.8, 22.7 and 6.1% of patients, respectively), and most were mild in nature. The efficacy and safety of sildenafil in this population of Korean men appears similar to that reported in other studies in western populations.
Similar articles
- ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan.
Chen KK, Hsieh JT, Huang ST, Jiaan DB, Lin JS, Wang CJ; ASSESS-3 Study Group. Chen KK, et al. Int J Impot Res. 2001 Aug;13(4):221-9. doi: 10.1038/sj.ijir.3900685. Int J Impot Res. 2001. PMID: 11494079 Clinical Trial. - The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study.
Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A; Thai investigators in ASSESS-2 Study Group. Kongkanand A, et al. J Med Assoc Thai. 2003 Mar;86(3):195-205. J Med Assoc Thai. 2003. PMID: 12757058 Clinical Trial. - Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study.
Gómez F, Davila H, Costa A, Acuña A, Wadskier LA, Plua P; Andean Group of Erectile Dysfunction Study. Gómez F, et al. Int J Impot Res. 2002 Aug;14 Suppl 2:S42-7. doi: 10.1038/sj.ijir.3900897. Int J Impot Res. 2002. PMID: 12161767 Clinical Trial. - Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.
Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ. Fink HA, et al. Arch Intern Med. 2002 Jun 24;162(12):1349-60. doi: 10.1001/archinte.162.12.1349. Arch Intern Med. 2002. PMID: 12076233 Review.
Cited by
- Erectile dysfunction.
Khera M, Goldstein I. Khera M, et al. BMJ Clin Evid. 2011 Jun 29;2011:1803. BMJ Clin Evid. 2011. PMID: 21711956 Free PMC article. Review. - Prevalence and medical management of erectile dysfunction in Asia.
Park K, Hwang EC, Kim SO. Park K, et al. Asian J Androl. 2011 Jul;13(4):543-9. doi: 10.1038/aja.2010.131. Epub 2011 Apr 4. Asian J Androl. 2011. PMID: 21460862 Free PMC article. Review. - Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis.
Guo YL, Viswanathan VP, Chiang HS, Choi HK, Yip AW, Shen W, Kopernicky V. Guo YL, et al. Asian J Androl. 2009 Jul;11(4):423-33. doi: 10.1038/aja.2009.11. Epub 2009 Apr 20. Asian J Androl. 2009. PMID: 19377488 Free PMC article. - Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction.
Moore RA, Derry S, McQuay HJ. Moore RA, et al. BMC Urol. 2005 Dec 14;5:18. doi: 10.1186/1471-2490-5-18. BMC Urol. 2005. PMID: 16354303 Free PMC article. Review. - Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases.
Brock G, Ni X, Oelke M, Mulhall J, Rosenberg M, Seftel A, D'Souza D, Barry J. Brock G, et al. J Sex Med. 2016 May;13(5):860-75. doi: 10.1016/j.jsxm.2016.02.171. J Sex Med. 2016. PMID: 27114197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical